Companies: 10,795·Total market cap: $144.5T
Cytosorbents Corporation

Cytosorbents Corporation

CTSONASDAQHealthcare● Active
$0.41
$-0.04(-9.76%)
Market Cap$26009585
P/E Ratio
52W High$1.39
52W Low$0.408

Cytosorbents Corporation (CTSO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ctso · stock forecast · 13 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
12
Hold
1
Sell
0
Strong Sell
0
Total: 13 · Buy rate: 92.3%

12-Month Price Target

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.41

The Cytosorbents Corporation (CTSO) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month CTSO price target is $0.00, representing +0.0% upside from the current price of $0.41.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$0.403.34%

1-day model range: $0.39–$0.41. Peak: $0.41 (-3.34%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027-50.0%
2028-62.5%
2029-67.2%
2030-69.2%
2031-70.2%
Confidence:Very Low
⚠️ 2027 projections carry Very Low confidence. Treat as directional guidance only.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)31.9
MACDBEARISH

Moving Averages · CTSO · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.47SELL
MA 10$0.47SELL
MA 20$0.50SELL
MA 50$0.56SELL
MA 100$0.63SELL
MA 200$0.72SELL
Current $CTSO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.46SELL
EMA 10$0.47SELL
EMA 20$0.50SELL
EMA 50$0.55SELL
EMA 100$0.61SELL
EMA 200$0.70SELL
Current $CTSO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
D. Boral Capital2026-03-26
Maintains
BuyBuy
D. Boral Capital2026-01-12
Maintains
BuyBuy
D. Boral Capital2025-12-16
Maintains
BuyBuy
D. Boral Capital2025-11-14
Maintains
BuyBuy
HC Wainwright & Co.2025-11-14
Maintains
NeutralNeutral
D. Boral Capital2025-09-16
Maintains
BuyBuy
D. Boral Capital2025-08-20
Maintains
BuyBuy
D. Boral Capital2025-08-08
Maintains
BuyBuy
D. Boral Capital2025-07-21
Maintains
BuyBuy
D. Boral Capital2025-06-25
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Cytosorbents Corporation (CTSO) stock. Of the recent 48 rating actions, 0 were upgrades and 1 were downgrades. 13 analysts currently cover CTSO.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

CTSO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$39M

↓ 23.7% YoY

Revenue Next Year

$47M

↑ 19.7% YoY

EPS This Year

$-0.17

EPS Next Year

$0.03

↓ 117.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CTSO EPS of $-0.17 for the current fiscal year, based on estimates from 2 analysts. The CTSO revenue forecast is $39M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CTSO stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CTSO price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.

The CTSO short-term stock prediction for tomorrow is $0.40 (-3.34%). The CTSO stock prediction for 2030 projects a range of $0–$0.

Cytosorbents Corporation trades on NASDAQ under the ticker CTSO. The CTSO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 92% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CTSO forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month CTSO price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.41.

CTSO price targetWhat is CTSO price targetCTSO analyst price targetCTSO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.